S&P 500   3,803.48
DOW   30,988.64
QQQ   316.19
S&P 500   3,803.48
DOW   30,988.64
QQQ   316.19
S&P 500   3,803.48
DOW   30,988.64
QQQ   316.19
S&P 500   3,803.48
DOW   30,988.64
QQQ   316.19
Log in
ASX:ACR

Acrux Limited (ACR.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.14
MA: A$0.13
A$0.14
52-Week Range N/A
Volume4,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Acrux Limited, together with its subsidiaries, develops and commercializes generic and specialty topical pharmaceuticals in Australia, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. Acrux Limited was founded in 1998 and is based in West Melbourne, Australia.

MarketRank

Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-3-83790100
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.25 million
Book ValueA$0.08 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive ACR News and Ratings via Email

Sign-up to receive the latest news and ratings for ACR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Acrux Limited (ACR.AX) (ASX:ACR) Frequently Asked Questions

What stocks does MarketBeat like better than Acrux Limited (ACR.AX)?

Wall Street analysts have given Acrux Limited (ACR.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Acrux Limited (ACR.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Acrux Limited (ACR.AX)'s earnings last quarter?

Acrux Limited (ACR.AX) (ASX:ACR) issued its quarterly earnings data on Thursday, February, 21st. The company reported ($0.02) EPS for the quarter.
View Acrux Limited (ACR.AX)'s earnings history
.

Who are some of Acrux Limited (ACR.AX)'s key competitors?

What other stocks do shareholders of Acrux Limited (ACR.AX) own?

Who are Acrux Limited (ACR.AX)'s key executives?

Acrux Limited (ACR.AX)'s management team includes the following people:
  • Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBus, CEO, MD & Exec. Director (Age 55, Pay $510.01k)
  • Ms. Deborah Ambrosini, CFO & Company Sec. (Age 47, Pay $298.55k)

What is Acrux Limited (ACR.AX)'s stock symbol?

Acrux Limited (ACR.AX) trades on the ASX under the ticker symbol "ACR."

How big of a company is Acrux Limited (ACR.AX)?

Acrux Limited (ACR.AX) has a market capitalization of $0.00 and generates $1.25 million in revenue each year.

What is Acrux Limited (ACR.AX)'s official website?

The official website for Acrux Limited (ACR.AX) is www.acrux.com.au.

How can I contact Acrux Limited (ACR.AX)?

Acrux Limited (ACR.AX)'s mailing address is 103-113 Stanley St, MELBOURNE, VIC 3003, Australia. The company can be reached via phone at +61-3-83790100.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.